UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

The Journal of pharmacology and experimental therapeutics, 2002-06, Vol.301 (3), p.1067-1078

2002

Volltextzugriff (PDF)

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

International Journal of Obesity, 2004-04, Vol.28 (4), p.640-648

2004

Volltextzugriff (PDF)

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Volltextzugriff (PDF)

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

Behavioural pharmacology, 1998-03, Vol.9 (2), p.179-181

1998

Volltextzugriff (PDF)

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Journal of physiology, 1998-08, Vol.510 (3), p.867-879

1998

Volltextzugriff (PDF)

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

Molecular pharmacology, 2003-04, Vol.63 (4), p.908-914

2003

Volltextzugriff (PDF)

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Psychopharmacologia, 1996-07, Vol.126 (2), p.165-172

1996

Volltextzugriff (PDF)

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

Psychopharmacologia, 2001-11, Vol.158 (3), p.241-251

2001

Volltextzugriff (PDF)

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Behavioural pharmacology, 2002-09, Vol.13 (5-6), p.451-463

2002

Volltextzugriff (PDF)

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Molecular psychiatry, 2004-03, Vol.9 (3), p.278-286

2004

Volltextzugriff (PDF)

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function

The Journal of pharmacology and experimental therapeutics, 2001-11, Vol.299 (2), p.449

2001

Volltextzugriff (PDF)

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Psychopharmacologia, 1998-02, Vol.135 (4), p.324-332

1998

Volltextzugriff (PDF)

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

The Journal of pharmacology and experimental therapeutics, 2003-07, Vol.306 (1), p.407-420

2003

Volltextzugriff (PDF)

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.145-155

2005

Volltextzugriff (PDF)

SR 142801, The first potent non-peptide antagonist of the tachykinin NK 3 receptor

Life sciences (1973), 1994, Vol.56 (1), p.PL27-PL32

1994

Volltextzugriff (PDF)

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Volltextzugriff (PDF)

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

British journal of pharmacology, 1994-06, Vol.112 (2), p.352-354

1994

Volltextzugriff (PDF)

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Life sciences (1973), 1995, Vol.56 (23), p.1941-1947

1995

Volltextzugriff (PDF)

Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex

The European journal of neuroscience, 2003-03, Vol.17 (5), p.981-990

2003

Volltextzugriff (PDF)

The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate-GABA Interaction via the Pallidal-Subthalamic Nucleus Loop

The Journal of neuroscience, 1998-09, Vol.18 (17), p.6977-6989

1998

Volltextzugriff (PDF)

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Journal of neurophysiology, 2000-06, Vol.83 (6), p.3287-3293

2000

Volltextzugriff (PDF)

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

The FASEB journal, 2005-09, Vol.19 (11), p.1567-1569

2005

Volltextzugriff (PDF)

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Neuroscience letters, 2003-06, Vol.343 (3), p.216-218

2003

Volltextzugriff (PDF)

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

Neuroscience and biobehavioral reviews, 2001-12, Vol.25 (7-8), p.619-626

2001

Volltextzugriff (PDF)

1 – 25 von 372

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(343)
Mit Volltextzugriff
(292)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(215)
Science & Technology
(194)
Life Sciences & Biomedicine
(180)
Male
(171)
Rats
(149)
Biological And Medical Sciences
(133)
Neurosciences & Neurology
(113)
Neurosciences
(111)
Pharmacology & Pharmacy
(96)
Medical Sciences
(81)
Pharmacology. Drug Treatments
(71)
Mice
(66)
Neuropharmacology
(64)
Rats, Sprague-Dawley
(61)
Humans
(59)
Piperidines - Pharmacology
(58)
Psychology. Psychoanalysis. Psychiatry
(52)
Fundamental And Applied Biological Sciences. Psychology
(51)
Pyrazoles - Pharmacology
(47)
Dose-Response Relationship, Drug
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Psychopharmacology
(32)
Neuroscience
(24)
European Journal Of Pharmacology
(23)
Psychopharmacologia
(23)
The Journal Of Pharmacology And Experimental Therapeutics
(17)
Neuropeptides
(16)
Brain Research
(14)
Neuroscience Letters
(13)
Behavioural Pharmacology
(12)
Journal Of Neurochemistry
(11)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

SR 142801, The first potent non-peptide antagonist of the tachykinin NK 3 receptor

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex

The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate-GABA Interaction via the Pallidal-Subthalamic Nucleus Loop

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

Suchergebnisse filtern